skip-navigation

STEVE STIVERS

Share |

Press Releases

Stivers, Welch Introduce Bill to Increase Access, Drive Down Costs and Increase Competition for Generic Pharmaceuticals

f t # e
Washington, September 18, 2014 | comments
WASHINGTON D.C. – Today, Rep. Steve Stivers (R-OH) joined Rep. Peter Welch (D-VT) to introduce the Fair Access for Safe and Timely (FAST) Generics Act to increase consumer access to generic drugs, boost market competition and ultimately save consumers money.
share: f t

 

WASHINGTON D.C. – Today, Rep. Steve Stivers (R-OH) joined Rep. Peter Welch (D-VT) to introduce the Fair Access for Safe and Timely (FAST) Generics Act to increase consumer access to generic drugs, boost market competition and ultimately save consumers money.

“We cannot afford to promote practices that hinder consumers’ abilities to obtain generic alternatives to expensive brand medicines,” said Stivers.  “Our bill closes federal loopholes to ensure consumers have increased access to less costly generic drugs by increasing market competition and eliminating bureaucratic red tape.  This problem must be addressed to save the government and consumers billions of dollars while increasing pharmaceutical options for patients.”

Currently, there are companies that abuse Food and Drug Administration (FDA) drug safety programs by withholding access to drug samples for generic manufacturers, resulting in anticompetitive practices and increased pharmaceutical costs.

“Too many Americans, particularly seniors, cannot afford their prescription drugs,” said Welch. “This legislation will ensure that manufacturers of generic medicines can bring more affordable medicines to the market as quickly as possible.”  

According to a study conducted by Matrix Global Advisors, companies using FDA safety programs as a smokescreen for these practices are costing American consumers $5.4 billion annually, including a lost savings of $1.8 billion for the federal government.

To read the Matrix Global Advisors report, please click here.

To read the Fair Access for Safe and Timely (FAST) Generics Act, please click here.

###
f t # e